Micro Emerging Active

KOD stock surge: risultati per la retinopatia diabetica

New narrative with limited coverage — still forming.

Punteggio
0,5
Velocità
▲ 1,0
Articoli
2
Fonti
1

Sentiment Timeline

Event Timeline

Apr 12, 2026
Kodiak Sciences (KOD) Reports Q4 EPS of ($1.05) Neutral
Mar 28, 2026
Kodiak Sciences (KOD) Climbs 75% on Stellar Clinical Results Neutral

Cronologia

Prima apparizioneMar 28, 2026
Ultimo aggiornamentoMar 28, 2026